Teva Pharmaceutical Industries Limited (TEVA)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Teva Pharmaceutical Industries Limited (TEVA) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $41.20B, a trailing price-to-earnings ratio of 15.4 and a free-cash-flow yield of 2.8%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share grew 49.0%.

Market cap	$41.20B
Trailing P/E	15.4
FCF yield	2.8%
Revenue growth (YoY)	+4.3%
EPS growth (YoY)	+17.3%
FCF/share growth (YoY)	+49.0%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live TEVA data on Nama Insights →

Recent Congressional trades

Teva Pharmaceutical Industries Limited trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Greg Gianforte	House	Buy	$15,001 - $50,000	Nov 16, 2020
Donna Shalala	House	Sell	$1,001 - $15,000	May 7, 2020
Patty Murray	Senate	Sell	$1,001 - $15,000	—
Angus S King, Jr.	Senate	Sell	$1,001 - $15,000	—
K. Michael Conaway	House	Sell	$1,001 - $15,000	Sep 15, 2016
K. Michael Conaway	House	Sell	$1,001 - $15,000	May 6, 2016
K. Michael Conaway	House	Sell	$1,001 - $15,000	Feb 12, 2015
Thomas MacArthur	House	Sell	$1,001 - $15,000	Feb 1, 2015
Alan S. Lowenthal	House	Buy	$15,001 - $50,000	Dec 24, 2014